| 37366315 | Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. | | 2023 |
| 37990652 | Letter to the Editor of O from the Obesity Medicine Fellowship Council. | | 2023 |
| 36268562 | Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society. | | 2022 |
| 36280397 | Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society. | American Journal of Kidney Diseases | 2022 |
| 35629934 | The Obesogenic and Glycemic Effect of Bariatric Surgery in a Family with a Melanocortin 4 Receptor Loss-of-Function Mutation. | Metabolites | 2022 |
| 34602251 | Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. | Gastroenterology | 2021 |
| 33965067 | Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174â¿¿772 participants. | Lancet, The | 2021 |
| 33113371 | Endocannabinoid Receptor-1 and Sympathetic Nervous System Mediate the Beneficial Metabolic Effects of Gastric Bypass. | Cell Reports | 2020 |
| 32313674 | The cost-effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity. | Obesity Science and Practice | 2020 |
| 32127716 | Joint international consensus statement for ending stigma of obesity. | Nature Medicine | 2020 |
| 32243693 | A Call to Better Understanding: Action Will Follow. | Obesity (Silver Spring) | 2020 |
| 31002795 | Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood. | Cell | 2019 |
| 31840077 | GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI. | Sci Adv | 2019 |
| 30421844 | A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. | | 2019 |
| 31231960 | Erratum: A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. | | 2019 |
| 30794300 | Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. | JAMA network open | 2019 |
| 29420964 | Metabolic Surgery: Weight Loss, Diabetes, and Beyond. | J Am Coll Cardiol | 2018 |
| 30358149 | Reply to "Response to Harris et al." | | 2018 |
| 30202815 | Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity. | Hepatol Commun | 2018 |
| 30293771 | Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. | Lancet | 2018 |
| 29956489 | Underdocumentation of Obesity by Medical Residents Highlights Challenges to Effective Obesity Care. | | 2018 |
| 29086529 | Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study. | | 2018 |
| 27957699 | Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations. | Obesity Surgery | 2017 |
| 29031371 | ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. | Gastrointestinal Endoscopy | 2017 |
| 29030161 | ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. | | 2017 |
| 29120742 | The Human Microbiome and Obesity: Moving beyond Associations. | | 2017 |
| 27880977 | Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. | Hepatology | 2017 |
| 27784062 | Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity. | JAMA Surgery | 2017 |
| 28111204 | Eat Well, or Get Roommates Who Do. | | 2017 |
| 28292401 | What Bariatric Surgery Can Teach Us About Endoluminal Treatment of Obesity and Metabolic Disorders. | Gastrointestinal Endoscopy Clinics of North America | 2017 |
| 27519448 | Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study. | Diabetes Care | 2016 |
| 27026085 | Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice. | American Journal of Physiology - Endocrinology and Metabolism | 2016 |
| 26806052 | Cortical and trabecular deterioration in mouse models of Roux-en-Y gastric bypass. | | 2016 |
| 27222544 | Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. | Diabetes Care | 2016 |
| 26465084 | Clinical Factors Associated With Remission of Obesity-Related Comorbidities After Bariatric Surgery. | JAMA Surgery | 2016 |
| 27568469 | Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. | | 2016 |
| 26066076 | Weight Loss After RYGB Is Independent of and Complementary to Serotonin 2C Receptor Signaling in Male Mice. | Endocrinology | 2015 |
| 25595796 | Weight loss, saline loading, and the natriuretic peptide system. | J Am Heart Assoc | 2015 |
| 26501192 | Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. | Nat Med | 2015 |
| 26339506 | The Role of Obesity Training in Medical School and Residency on Bariatric Surgery Knowledge in Primary Care Physicians. | | 2015 |
| 24560870 | Role of the microbiome in energy regulation and metabolism. | Gastroenterology | 2014 |
| 24148361 | What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat Clostridium difficile Infection? | Clin Gastroenterol Hepatol | 2014 |
| 23929784 | Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. | Journal of Bone and Mineral Research | 2014 |
| 24274861 | Obesity and liver disease: the epidemic of the twenty-first century. | Clinics in Liver Disease | 2014 |
| 23536013 | Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. | Sci Transl Med | 2013 |
| 23567924 | Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. | International Journal of Obesity | 2013 |
| 23567348 | Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery. | Gastroenterology | 2013 |
| 23643386 | Weight loss after gastric bypass is associated with a variant at 15q26.1. | Am J Hum Genet | 2013 |
| 23670991 | Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass. | | 2013 |
| 23223024 | Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients. | Diabetes | 2013 |